Chimeric molecule for the treatment of TH2-like cytokine mediated disorders

Details for Australian Patent Application No. 2002258011 (hide)

Owner The Government of the United States, as represented by The Secretary of the Department of Health and Human Services National Institutes of Health The Regents of the University of Michigan

Inventors Hogaboam, Cory M; Kunkel, Steven L; Puri, Raj K; Jakubzick, Claudia

Agent Pizzeys

Pub. Number AU-B-2002258011

PCT Pub. Number WO2003/047632

Priority 60/337,179 04.12.01 US

Filing date 28 February 2002

Wipo publication date 17 June 2003

Acceptance publication date 8 January 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002258011

8 January 2009 Application Accepted

  Published as AU-B-2002258011

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258012-DIRECTIONAL CONTROL VALVE COMPRISING AN INTERNAL PRESSURE REGULATOR

2002258010